CClinicalTrials.gg
CompletedNCT03425981Updated Feb 8, 2018

Effects of WB-EMS in Runners.

An interventional study of Whole-Body Electromyostimulation Training in Physical Activity, sponsored by Universidad de Granada. Completed at 1 site in Spain. Open to male participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-02-08.

Sponsored by Universidad de Granada · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Randomized
Sex
Male
01

Study summary

The subjects will be randomly distributed into 3 experimental groups: training with basic global electrostimulation (WB-EMS-SRT), training with specific global electrostimulation for runners (WB-EMS-WT) and control group (CG).

Initially and at the end of the intervention period, which will consist of six weeks, the subjects will undergo a series of tests: (1) Maximum incremental effort test in tapestry to exhaustion to determine cardiorespiratory capacity (VO2max) and thresholds (aerobic and anaerobic). (2) Submaximal carpet test at constant speed to determine race economy (EC). (3) Lower train power test (CMJ and Abalakov). (4) Weight, size and waist circumference. The aforementioned tests will be carried out on different days to avoid the effect of fatigue on performance with a break of more than 48 hours between tests.

The participants in the control group will maintain the volume and intensity of the training prior to the intervention study and the subjects of the WB-EMS and WB-EMS-AC groups will substitute one conventional training day for one with global electrostimulation for six weeks; the training of the first group will be non-specific and that of the second specific for runners and the duration of both will be 20 minutes.

Read the detailed description

A randomized controlled trial design was applied following CONSORT statements. After baseline measurements, participants were randomized into two groups: (i) WB-EMS group and (ii) Control Group (CG). Participants in the WB-EMS group were instructed to reduce their running training program volume, whereas the CG continued with their running training in term of volume and intensity: two or three times per week (45-60 minutes per day) at an intensity of 60-70% hearth rate reserve, which was controlled by heart rate monitor (Polar RS300X, POLAR, Kempele, Finland), and with 24-48 hours of rest between sessions

02

Conditions studied

  • Physical Activity

Keywords

  • WB-EMS
  • Running economy
  • VO2max
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Frequent runners

Exclusion criteria

Exclusion Criteria:

  • Received WB-EMS training.
04

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
14 participants (actual)

Study arms

  • Experimental
    WB-EMS-SRT

    Training with basic global electrostimulation

    Other: Whole-Body Electromyostimulation Training

  • Experimental
    WB-EMS-WT

    Training with specific global electrostimulation for runners

    Other: Whole-Body Electromyostimulation Training

  • Placebo comparator
    CG

    The participants in the control group will maintain the volume and intensity of the training prior to the intervention study and the subjects of the WB-EMS and WB-EMS-AC groups will substitute one conventional training day for one with global electrostimulation for six weeks; the training of the first group will be non-specific and that of the second specific for runners and the duration of both will be 20 minutes.

    Other: Whole-Body Electromyostimulation Training

Interventions

  • OtherWhole-Body Electromyostimulation Training

    The WB-EMS training program consisted of six WB-EMS training sessions (one per week) and six running training sessions (also one per week). This intervention programme followed a within-day undulating periodization model. The training sessions were divided into four parts: warm up (A), strength (B), high intensity interval power training (c), and high intensity interval training (HIIT) (D).

05

What researchers measure

Primary outcomes

  1. Maximal oxygen consumption

    Maximal Oxygen consumption was assessed using a maximum treadmill (H/P/ Cosmos Pulsar treadmill, H/P/Cosmos Sport \& Medical GMBH, Germany) exercise test with a progressive incremental protocol that has been used.

    Time frame: Baseline and through study completion, an average of 5 weeks

Secondary outcomes

  1. Ventilatory thresholds

    VT1 and VT2 were estimated from gas exchange data through different respiratory variables: minute ventilation (VE) and equivalents for oxygen (VE/VO2) and carbon dioxide (VE/VCO2) by two independent researchers

    Time frame: Baseline and through study completion, an average of 5 weeks

  2. Running economy

    RE was determined during a treadmill test following a specific protocol used in previous studies

    Time frame: Baseline and through study completion, an average of 5 weeks

  3. Muscular power

    Vertical jump performance was assessed using the Bosco Test.

    Time frame: Baseline and through study completion, an average of 5 weeks

  4. Weight

    Weight in Kilograms

    Time frame: Baseline and through study completion, an average of 5 weeks

  5. Body composition

    Assessed using DXA.

    Time frame: Baseline and through study completion, an average of 5 weeks

06

Study locations

1 site
  • Medicine Faculty
    Granada, 18001, Spain
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03425981
Lead sponsor
Universidad de Granada
Responsible party
Manuel Castillo Garzón (University professor, Universidad de Granada) — Principal investigator
First posted
Feb 8, 2018
Start date
Dec 1, 2017
Primary completion
Dec 15, 2017
Completion
Jan 15, 2018
Last update
Feb 8, 2018

Study contacts

Baseline and post Castillo Garzón, University Proffesor
study director · Universidad de Granada

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion